Athersys Announces Successful Type B Meeting with the FDA
Athersys , Inc. (NASDAQ:ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced planned amendments to its...
Neutral
or
Athersys News & Analysis
-
-
: Athersys started at buy with $5.50 stock price target at Alliance Global
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about...
-
Athersys Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol Discussion
Athersys , Inc. (NASDAQ:ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today that the Company has...
-
Athersys Earnings beat, Revenue misses In Q3
Investing.com - Athersys reported on Thursday third quarter {{erl-15486||earnings that beat analysts' forecasts and revenue that fell short of expectations. Athersys announced earnings per...
-
Pre-Open Movers: Workday, Farfetch Gain on EPS; Seagen Falls on Deal Worries
Pre-Open Stock Movers:Farfetch Limited (NYSE:FTCH) 17% HIGHER; reported Q2 EPS of ($0.17), $0.13 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $579.3...
-
After-Hours Movers: Workday Jumps on Strong EPS; Affirm, Dell Fall on Weak Results
After-Hours Stock Movers:Everbridge, Inc. (NASDAQ:EVBG) 15% HIGHER; the company is exploring a sale, Bloomberg reported. Affirm Holdings (NASDAQ:AFRM) 14% LOWER; reported Q4 EPS of ($0.65),...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.03%
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Healthcare, Telecoms and Oil & Gas sectors propelled shares higher while losses in the Consumer Goods,...
-
Athersys Tops Q1 EPS by 1c
Athersys (NASDAQ:ATHX) reported Q1 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.9 million versus the consensus estimate of...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.26%
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Healthcare, Financials and Technology sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.19%
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Oil & Gas, Technology and Healthcare sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.80%
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Healthcare, Technology and Basic Materials sectors propelled shares higher while losses in the Utilities, Oil...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.14%
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Healthcare, Consumer Services and Technology sectors propelled shares higher. At the close in NYSE, the...
-
Top 5 Things to Know in the Market on Wednesday
Investing.com - Here are the top five things you need to know in financial markets on Wednesday, November 8: 1. Dollar Stalls Amid U.S. Tax Reform Jitters The dollar steadied against other...
-
US STOCKS-Futures flat as earnings season kicks off
* Futures down: Dow 8 pts, S&P 1.75 pts, Nasdaq 3.25 ptsBy Sruthi ShankarOct 11 (Reuters) - U.S. stock index futures were little changed on Wednesday, with investors watching out for the...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.04%
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Healthcare, Telecoms and Technology sectors propelled shares higher while losses in the Oil & Gas, Financials...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
